Smallanthus sonchifolius (Yacon, Asteraceae) was originally cultivated in South America and used in traditional medicine by Andean inhabitants. Yacon is known to be potentially beneficial for the management of diabetes. Yacon is composed of fructooli...
Smallanthus sonchifolius (Yacon, Asteraceae) was originally cultivated in South America and used in traditional medicine by Andean inhabitants. Yacon is known to be potentially beneficial for the management of diabetes. Yacon is composed of fructooligosaccharides, proteins, minerals and phenolic compounds. The aim of study is to investigate hypoglycemic effect of yacon tuber extract (YTE) and its constituent, chlorogenic acid (CGA), in streptozotocin(STZ)-induced diabetic rats. In this study, a HPLC method was developed for simultaneous determination of major active phenolic components, CGA and caffeic acid in YTE. We investigated the hypoglycemic effect of YTE and CGA in STZ-induced diabetic rats and studied glucose tolerance test (GTT). The effect of orally administered multiple dose of YTE and CGA on plasma biochemical parameters was examined using diabetic rats. We also measured free radical scavenging activity by the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay and determined nitric oxide (NO) production. The stability test of pharmaceutical formulations (tablet and suspension) of YTE was studied under accelerated condition. The oral administration of YTE (200mg/kg) and CGA (10mg/kg) for 6 weeks produced significant hypoglycemic effect on STZ-induced diabetic rats. YTE and CGA-treated groups showed significant decrease in plasma glucose surge during the GTT. Total cholesterol (TC) and triglyceride (TG) concentrations were significantly decreased by 33 % and 49 %, respectively in YTE-treated rats. TC and TG concentrations were also significantly decreased by 26 % and 41 %, respectively in CGA-treated rats. In the DPPH assay, free radical scavenging activity of CGA was similar to vitamin E, a positive control in the assay. YTE and CGA were found to prevent NO production. CGA concentration in yacon tuber tablet and suspension remained 92 % and 79 %, respectively after 6 months of the accelerated stability test (40 ± 2 ℃, 75 ± 5 % RH). This study suggests that YTE and its constituent, CGA, may be an useful option for management of hyperglycemia and diabetic nephropathy.